British startup Mass Balance has launched a grapefruit-sized autonomous laboratory into orbit via a SpaceX transporter to advance longevity research. Contained within a 10-centimeter Tumbleweed pod, the apparatus will orbit Earth for several months, utilizing sensors to monitor chemical reactions and cell behavior in microgravity. This mission aims to overcome Earth-based research obstacles like convection and sedimentation, which often obscure data regarding disordered proteins. These proteins are central to age-related diseases such as Alzheimer’s and Parkinson’s, but their shifting shapes on Earth hinder accurate AI modeling. By studying these proteins in space, Mass Balance intends to train AI models to better predict medicinal responses. While competitors like BioOrbit and Varda Space Industries focus on returning payloads to Earth, Mass Balance is prioritizing data transmission, aiming to make space a reliable, standardized environment for pharmaceutical and life science research.